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INTRODUCTION 
 
Colorectal cancer (CRC) is the fourth most common cancer in men and the third most 
common in women, with mortality paralleling incidence1, in the mid-1970s, approximately 
60 cases of colorectal cancer were diagnosed per 100,000 people in the United States, and 
approximately 51% of those diagnosed survived their disease at least five years. Over the 
last two decades, incidence rates have fallen by nearly 26% between 1984 and 2004. This 
decline is likely due to increased colorectal cancer screening, which allows physicians to 
detect and remove colorectal polyps before they progress to cancer. United States Preventive 
Services Task Force (USPSTF) recommended screening for CRC should be performed in all 
persons aged 50 years and older2. Yet, incidence is still high: colorectal cancer is the third 
most commonly diagnosed cancer for both men and women. As of 2004, approximately 48 
cases of colorectal cancer were diagnosed per 100,000 people in the United States. About 
65% of men and women diagnosed with colorectal cancer now survive their disease at least 
five years. American Cancer Society recommended the following screening tool for CRC, 
which includes fecal occult blood test (FOBT) annually, flexible sigmoidoscopy every 5 
years as an option, colonoscopy as an option every 10 years, double contrast barium enema 
recommended every 5 years as an option3. Colonoscopy is the gold-standard for evaluation 
of colonic pathology, but in certain situation where colonoscopy is not possible or 
incomplete due to procedural pain, colonic stenosis; elongated colon may be found in up to 
26% of patients4. Thus there has been a need to develop alternative diagnostic procedure to 
visualize large bowel.    
Currently available modalities like Barium enema, which has following drawbacks like 1) 
Highly subjective 2) Bowel loop superimposed with one another   without cross sectional image 
to see the small lesions 3) Risk of ionizing radiation.  
CT Colonography is another alternative but it carries the risk of excessive ionizing radiation and 
contrast exposure. MR Colonography (MRC) is technically similar to CT Colonography with 
few advantages. 
In recent years major technologic advances in diagnostic MRI have led to improve image quality 
particularly with the use of Fast sequence and surface coil. Positive contrast like water/saline can 
be used to distend the colonic lumen; hence without radiation and contrast material we can study 
the colon using this technique.5,6  
Sixty patients with suspected colonic pathology were evaluated, thirty patients underwent 
colonoscopy first then MRC, another thirty patients underwent MRC first which was followed by 
colonoscopy. Findings in both modalities were compared to know the merits and demerits of 
each modality.   
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
AIM OF THE STUDY 
 
 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVE OF THE STUDY 
 
1. To find out the merits and demerits of standard tool colonoscopy and newer modality 
Magnetic Resonance Colonography (MRC) in assessing the various colonic pathology. 
2. To find out the Sensitivity, Specificity. Positive predictive value and Negative predictive 
value of MRC in comparison with standard tool Colonoscopy 
3. To find out the role of MRC in patients with obstructive type of colonic lesion were 
further scope passage was not possible 
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REVIEW OF LITERATURE 
 
HISTORY OF COLONOSCOPY  
Although the first telescopes were developed in Europe in the early 17th century, it was Phillipp 
Bozzini who first actually tried to observe inside the human body, through a rigid tube without 
optics. He developed an apparatus called the light conductor (Lichtleiter) in 1805, which he used 
in his attempt to observe rectum, larynx, urethra, and upper esophagus 7.  
In 1853, Désormeaux (1815–81) of France developed the first endoscope of practical value and 
called this instrument an “endoscope” for the first time in history. Désormeaux utilized his 
instrument  for diagnosis and treatment of urological diseases. Désormeaux’s endoscope was 
essentially a mere hollow rigid tube and did not have a lens in its optical system.  
It was Kussmaul who further developed Désormeaux’s method and succeeded in making the first 
gastroscope in 1868.  
In 1895 Kelly in the USA produced the first proctoscope of practical value8. In 1903 Strauss in 
Germany followed the Laws’ approach, developing a proctosigmoidoscope that distended the 
sigmoid colon with a rubber hand pump and safety bellows.   
Hirschowitz, Peters, and Curtiss, at the University of Michigan, developed a   fiberoptic viewing 
bundle by 1957 and used it to perform the first flexible gastroduodenoscopy.  By 1963, three 
different US teams had produced prototype short instruments and Overholt was able to perform 
the first flexible sigmoidoscopy with a relatively crude but four-way angling instrument. A 
prototype forward-viewing “colonofiberscope” was first made by Olympus for Niwa in 1965. 
Progress in electronics led to the American development in 1969 of silicon charge-coupled 
device (CCDs) containing picture elements (pixels) able to generate electric signals in response 
to light. Even though Japanese glass fibers were reduced down to 7 μm diameter, with reduced 
“packing fraction” between fibers and superior resolution, CCD images were able to be made 
several-fold higher in quality. Early CCDs were too large for small-diameter gastroscopes, so the 
first “videoendoscope” was a colonoscope produced in the USA by Welch-Allyn Company in 
1983 and reported by Sivak and Fleischer9. 
 
Because CCDs could transmit monochrome brightness of their individual elements but not color 
(the glass fiber was only for illumination), two methods were devised to display images in color, 
the “sequential system” and the “white light” or simultaneous system. With the sequential 
system, light emitted from the light source was converted into strobed colored light by means of 
rotating red (R), green (G), and blue (B) filters.  
Gradually, with miniaturization, CCDs became smaller and the number of pixels increased, 
resulting in high-quality images. 
However, an external diameter of 10–13 mm permits good maneuverability, the instrumentation 
channel should have an internal diameter of at least 2.8 mm to facilitate the passage of 
accessories 
From the spring steel stiffening wires used by some colonoscopists in the early 1970s there 
developed a stiffening wire and stiffening tube. The American Cystoscope Makers Inc. (ACMI) 
internal stiffening wire of 1974 consisted of a core tensioning wire surrounded by a 3.5-mm-
diameter coil. Tensioning the core wire, the outer coil contracted and stiffened. The large 
diameter required to achieve effective stiffening restricted use to large-channel “therapeutic 
colonoscopies,” such as the ACMI F9A. Thinner wires for standard colonoscopes did not 
produce the desired stiffness. 
 
Colonoscopy is the current standard for the diagnostic evaluation of the large intestine, using 
fiberoptic or video versions, every portion of the large bowel can be examined, and therapeutic 
maneuvers can be performed at any site. A coordinated series of manipulations permits safe 
intubation through the multiple turns and twists of the colon. An accessory channel allows 
passage of various instruments through the length of the colonoscope for biopsy or therapy. 
INDICATIONS 
The two major categories of indications for colonoscopic examination of the colon are diagnostic 
and therapeutic. 
Diagnostic 
1.  Screening for colorectal neoplasia is the most common indication 10 
2.  Symptom Evaluation like Bleeding or Change in bowel habits  
3.  Preoperative/postoperative evaluation of patients with colon cancer 
4.  Abnormal barium enema examination 
5.  Screening or surveillance for neoplasia in high-risk patients11 
    a. Ulcerative colitis or Crohn's disease of long-standing duration  
    b. Family history of polyps or cancer 
     c. Polyposis syndromes such as familial adenomatous polyposis or HNPCC12 
    d. Persons over 50 years of age 
Therapeutic 
1.  Polypectomy, the most frequent therapeutic intervention during colonoscopy 
2.  Hemostasis of bleeding lesions13 
3.  Stricture dilation 
4.  Removal of foreign bodies 
5.  Decompression (Ogilvie's syndrome or volvulus) 14, 15, 16 
CONTRAINDICATIONS 
Absolute 
1.  Peritonitis with or without bowel perforation 
2.  Acute diverticulitis 
3.  Recent myocardial infarction or pulmonary embolus17 
4.  Fulminant colitis 
Relative 
1.  Torrential colonic bleeding 
2.  Cardiopulmonary instability 
3.  Poor bowel preparation 
4.  Uncooperative patient 
COMPLICATIONS 
Related to diagnostic colonoscopy includes18, 19, 20 – Bacteremia, Hemorrhage,  Perforation, 
Diastatic serosal tears, Post colonoscopy distention, Vasovagal reflex, Volvulus, Colonic 
obstruction, Adynamic ileus,  Pneumatosis cystoides intestinalis, Incarceration of an instrument 
in a hernia, Impaction of a scope in a hernia, Aortic aneurysm dissection, Cardiopulmonary 
problems. 
Related to therapeutic colonoscopy includes21, 22, 23, 24 – Perforation, Hemorrhage, Mucosal 
burns, Incomplete polypectomy, Explosion, Accidental removal of a ureterosigmoidostomy 
stoma, Accidental removal of an intussuscepted appendiceal stump, Electrical ileal perforation 
PREPARATION 
The patient was informed about the indications for the procedure, alternative therapy, possible 
complications, and the possibility of overlooking lesions. 
BOWEL PREPARATION 
A colon free of solid stool is the goal, A one-day liquid diet is usually prescribed and we use 
polyethylene glycol25 for bowel preparation, one pocket to be mixed in two liters of water to be 
taken over a period of two hrs usually between 6:00 PM to 8:00 PM on previous day. 
 
EQUIPMENT 
1. Video Colonoscope – Pentax EC 3830/EC 3801L, 168 cm in length.  
2.  Light source and Image processor – EPM - 3300 
4.  Monitoring equipment (pulse, blood pressure monitor) 
5.  Ancillary equipment such as biopsy forceps, snares, electrosurgical unit, injector needle 
6.  Universal precautions with gloves, gowns, masks. 
 
REVIEW OF LITERATURE AND PROCEDURE 
COLONOSCOPY 
A colonoscopic examination was performed with the patient in the left lateral    position using a 
two-person team.  Colon inflated with air deflated with suction, by using angulations control 
wheels to manipulate the tip up/down or right/left; push the instrument in or withdraw it. After 
doing rectal examination scope inserted without sedation. Left hand used to adjust the knobs and 
the right hand to torque the instrument to provide directional changes while insertion or 
withdrawal of the shaft is performed simultaneously. The colon can be pleated onto the 
instrument shaft by jiggling the scope with rapid in-and-out motions during intubation, usually 
with clockwise torque. 
VIRTUAL COLONOGRAPHY (VC) 
Virtual Colonography (VC) was first introduced by Vining and colleagues26 in 1994 and has 
evolved during the last decade as a promising alternative to optical endoscopy. The concept of 
VC is based on the acquisition of cross-sectional images of the abdomen using either CT or MR 
imaging. Because of the administration of either liquid or gasiform distending media, the colonic 
wall can be assessed either on the acquired source data or on virtual endoscopic reformations27, 
28. VC overcomes some of the disadvantages of optical colonoscopy. 
The entire large bowel can be depicted even in the presence of stenotic lesions or elongated 
bowel segments. The data sets can be assessed in a multiplanar reformation mode on a 
postprocessing workstation, which enables the display of the colon from any desired angle. This 
type of multiplanar reformation analysis depicts the colonic wall, the colonic lumen, and all the 
surrounding abdominal morphology. Hence, analysis is not limited to the bowel itself. All 
adjacent abdominal structures can be assessed, so colonic lesions can be located more 
accurately29. Since the concept and method of doing MRC is similar to virtual Colonography, 
MRC has evolved as an alternative method that has several advantages over CTC, like no 
radiations, better soft tissue contrast and the use of non-nephrotoxic contrast 
MR COLONOGRAPHY (MRC) 
MR Colonography was first described in 1997 by Luboldt et al30. Currently two techniques are 
being evaluated for MR colonography.  Based on the signal within the colonic lumen, they can 
be differentiated as “Bright lumen”31,32,33 and “dark lumen” MRC.34 
In our institution we have 1.5 Tesla MRI, with that 1.5 Tesla MRI and the  software available in 
our institution i did my study. But ideally 3 Tesla MRI35,36 will give more information like better 
soft tissue plane delineation and especially for staging growth rectum. 
CURRENT ACCEPTED INDICATIONS FOR MRC 
Indications are extrapolated from CT Colonography, since both the modality is almost same 
with the advantage of no radiation with MRC. 
(1)Incomplete colonoscopy because an obstructing mass or stricture prevented examination of 
the proximal colon 
(2)Incomplete colonoscopy because of colonic tortuosity, adhesions, severe diverticular disease, 
or patient intolerance of colonoscopy 
(3)Inability to perform colonoscopy because of a strong requirement for anticoagulant therapy or 
risks of sedation 
(4)Patients who have a strong indication for diagnostic colonoscopy but who adamantly refuse to 
undergo colonoscopy 
RELATIVE CONTRAINDICATION FOR MRC 
(01) Severe allergy to administered contrast (MRC can be performed even without contrast) 
(02) Suspected colonic perforation or peritonitis 
(03) Walled off colonic leak/pericolonic abscess 
(04) Medically highly unstable patient (eg, unstable angina, uncontrolled sepsis) 
(05) Acute lower gastrointestinal bleeding 
(06) Pregnancy 
(07) Inability to tolerate pneumocolon/water instillation  
(08) Highly uncooperative patient 
(09) Inability to undergo colonic preparation: congestive heart failure, severe electrolyte 
imbalances, severe dehydration 
(10) Refusal to undergo colonic preparation 
(11) Abnormal anorectal anatomy (eg, imperforate anus, tight anal stricture) 
(12) Severe colonic disease (toxic colitis, toxic megacolon, severe colonic pseudoobstruction) 
(13) Acute colonic infection (acute diverticulitis, severe infectious colitis) 
(14) Complete mechanical colonic obstruction 
(15) Very recent colonic surgery (<1 week) 
Bright lumen MRC 
With “bright lumen” MRC31,32,33 colorectal lesions are visualized as dark filling defects within 
the bright colonic lumen. This can be achieved by administering a rectal enema containing 
paramagnetic contrast. On 3D gradient echo data sets only the contrast-containing colonic lumen 
is bright whereas the surrounding tissues including colonic wall and polyps and growth remain 
low in signal intensity. A new approach for “bright lumen” MRC is based on the acquisition of 
True FISP sequences.  
Using a rectal water-enema, the contrast mechanism is comparable to that of the approach in 
conjunction with a paramagnetic contrast enema and the acquisition of T1w GRE sequences. 
Since the True FISP technique neither requires the administration of intravenous nor rectal 
paramagnetic contrast medium, it appears economically attractive. 
The detection of colorectal lesions with “bright lumen” MRC relies on the visualisation of filling 
defects. Differential considerations for such a filling defect beyond polyps include air bubbles as 
well as residual faecal material. To permit differentiation datasets are collected in both the prone 
and supine patient position: air and faecal material move, while polyps remain stationary. While 
effective in most instances, the technique can introduce errors. Thus, polyps with along stalk 
may move sufficiently to impress as a moving air bubble or more probably residual stool, while 
stool adherent to the colonic wall may not move at all and, thus, falsely impress as a polyp. 
Dark lumen MRC 
In addition to obviating the need for the second, time consuming 3D data acquisition “dark 
lumen” MRC34 facilitates the identification of polyps.“Dark lumen” MRC focuses on the colonic 
wall. It is based on the contrast generated between a brightly enhancing colonic wall and a 
homogeneously dark colonic lumen.37 
The technique differs from “bright lumen” MRC in the following manner: 
1.  Instead of gadolinium containing enema only tap water is rectally applied rendering low 
signal on heavily T1weighted 3D GRE acquisitions. 
2.  The colonic filling process is monitored with a fluoroscopic T2w sequence, rather than a 
T1w sequence. 
3. To obtain a bright colonic wall paramagnetic contrast is applied intravenously.3D 
datasets are collected before the application and after a 75 second delay. 
4.  As residual air exhibits no signal in the colonic lumen, the examination needs to be 
performed only in the prone patient position. Furthermore, the “dark lumen” technique 
copes with the problem of residual stool in a simple manner: if the lesion enhances, it 
may be a polyp or growth; if it does not enhance, it represents stool. While most mass 
lesions smaller than 5 mm in size were missed,38 almost all lesions exceeding 8mm were 
correctly identified. MRC identified additional lesion in regions of the colon not reached 
by colonoscopy. 
MR colonography was described  in 1997 by Luboldt et al. 
After in 1997 Royster AP, Fenlon HM, Clarke PD, et al. used new technique of 3D virtual 
colonoscopy and compared with conventional colonoscopy. they concluded that MR virtual 
colonoscopy used for complete colonic examination and rectify some of 2D MR colonography 
drawback.39 
Vining and colleagues  in  1998 repeated virtual colonoscopy and compared with colonoscopy 
the results were promising and concluded as alternative to optical endoscopy, and virtual 
colonoscopy useful for complete examination of colon40 During 1999 Lubolt et al& Ajaj.w et al 
discussed about the need of colonic distension .Most colonic loops are collapsed in their 
physiologic state, the large bowel needs to be distended to allow a reliable assessment of the 
bowel wall. Otherwise, non distended colonic segments may mimic bowel wall thickening and 
lead to a misinterpretation of inflammation or even colorectal malignancy. Furthermore, smaller 
lesions, such as colorectal polyps, may be missed. To assure sufficient distension, the rectal 
administration of water, water-based fluids, air, or carbon dioxide has been proposed 41,42. 
 
In 2000, A trial by Luboldt W, Bauerfeind P, Wildermuth42 S, et al. Colonic masses: detection 
with MR colonography -demonstrated that diagnostic accuracy of  MRC was highly dependent 
on polyp size: although most polyps smaller than five mm were not detected by MRC, the 
sensitivity for the detection of polyps larger than 10 mm was greater than 90%.42 
Lauenstein TC, Goehde SC, Ruehm SG, et al. introduced faecal tagging method in 
2002.MRcolonography with barium-based faecal tagging- initial experience was favourable to 
differentiate polyp from faecal material in faecal tagging patients. faecal tagging avoid the need 
of tedious colonic preparation29 
During  2003-Ajaj W, Pelster G, Treichel U, et al. compared Dark lumen magnetic resonance 
colonography  with conventional colonoscopy for the detection of colorectal pathology. Dark 
lumen MRC was as sensitive and specific as colonoscopy in polyp deduction. Using  gadolinium 
contrast polyp seen brightly and extraluminal pathology were well made out43. 
Lauenstein TC, Ajaj W, Kuehle CA, et al.were compared  two different  Magnetic resonance 
colonography techniques in 2005. comparison of contrast-enhanced three-dimensional vibe with 
two-dimensional FISP sequences. preliminary experience shows 3D vibe is superior in 
demonstrate polyp than FISP.3D virtual colonoscopy and complete colonic examination is 
possible with 3D vibe sequence44 
Late in 2005-Ajaj W, Lauenstein TC, Pelster G, et al. demonstrate the advantages of  MR 
colonography in patients with incomplete conventional colonoscopy.MRC is useful to examine 
patients with distal colonic stenosis45 
During 2005-Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance 
imaging colonography with conventional colonoscopy for the assessment of other intestinal 
lesion like intestinal inflammation in patients with inflammatory bowel disease. The results were 
inconclusive.46 
After in2005-Hartmann D, Bassler B, Schilling D, et al. used MR colonography in patients 
Incomplete conventional colonoscopy and in the evaluation of the proximal colon.MRC is 
superior to colonoscopy in detection of proximal colon lesion in case of  distal 
stenosis/obstruction.47 
2006 -Rottgen R, Herzog H, Bogen P, et al. MR colonoscopy at 3.0 T: comparison with 1.5 T in 
vivo and a colon model36. 3T MRC gives high resolution and useful for 5mm polyp.  
2006-Hartmann D, Bassler B, Schilling D, et al. Colorectal polyps: detection with dark-lumen 
MRcolonography versus conventional colonoscopy. Extraluminal pathology well demonstrated 
by dark lumen MRC which is not possible by colonoscopy47 
In  2007-Kinner S, Kuehle CA, Langhorst J, et al. were compared MR colonography versus 
optical colonoscopy on the basis of patient acceptance, the results concluded that of  
MRcolonography  is equally  acceptable to colonoscopy in screening population48 
2007-Kuehle CA, Langhorst J, Ladd SC, et al. MR colonography without bowel cleansing—a 
prospective cross-sectional study in which concluded that fecal tagging is highly acceptable by 
screening population49 
Numerous factors can limit the accuracy of MRC: 
Stool/inadequately prepared colon(overcome with fecal tagging) 
Inadequate colonic distention 
Colonic spasm 
Uncooperative patient 
Motion artifacts from respiration 
Old MRI machine  
Inadequate radiologist training 
Flat (nonpolypoid) colonic lesions that are hard to detect by MRC 
Pitfalls of MRC 
Failure to detect a lesion may be due to technical factors (eg, bowel preparation, bowel 
distention), the primary reading technique, or reader skill and experience.  Misinterpretation of 
findings can be avoided by careful analysis of the morphology of every potential lesion on 
multiple views by changing patient position from supine to prone and vice versa.  
Polyps have rounded or lobulated contours and homogeneous soft tissue attenuation. Submucosal 
lesions can mimic the smooth and polypoid appearance of mucosal polyps.  
Bulbous colonic folds may mimic colonic polyps on 2D and 3D images, but sequential review of 
the suspected abnormality in the axial, coronal, and sagittal images should clarify that the 
abnormality represents a fold rather than a polyp. 
An inverted appendiceal stump may mimic a cecal lesion on 2D and 3D images. When a 
suspected lesion is demonstrated in the expected region of the appendiceal orifice, an attempt 
should be made to identify a normal appendix. 
If the appendix is not identified, it is important to determine whether the patient has had prior 
inversion-ligation appendectomy. A prominent ileocecal valve can mimic a cecal mass. 
Therefore, the ileocecal valve should be identified in every study. The normal valve often 
contains macroscopic fat. The terminal ileum also can be located and followed to the ileocecal 
valve on axial or coronal images. 
Table – 1 showed the comparison of sensitivity of polyp detection and other important factors of 
various imaging modalities.  
 
 
TABLE - 1 
 COLONOSCOPY AND OTHER IMAGING MODALITIES 
ADVANTAGES AND DISADVANTAGES 
Parameters  Colonoscopy DCBE CTC MRC 
Intervention possible Yes  No No No 
Portion of colon examine 80 -95% 90 – 95% 100% 100% 
Mucosal abnormality 
detection 
Yes  No  ? ? 
Sensitivity of polyp detection 
size < 1cm 
75% 50 – 80% 33 – 70% 61% 
Sensitivity of polyp detection 
size >1cm 
90% 75 – 95% 82 – 93% 96% 
Sensitivity for polyp &cancer 100% 95% 90 -97% 99% 
 Yes  No  Yes with Yes with 
Distinction of fecal residue 
from polyp 
contrast contrast 
Operator dependent  Yes  Yes  No  No  
Sedation req. Yes  No  No  No  
Patient preference  Low  Low  High  Undetermined 
Risk of perforation  1 in 1000 1 in 25000 Undetermined Undetermined 
Cost  High  Low  High  High  
 
DCBE – Double contrast Barium Enema 
CTC – CT Colonography 
MRC – MR Colonography 
 
COLORECTAL CANCER 
Colorectal adenocarcinoma is a major human health problem. Worldwide this malignancy affects 
one million individuals each year and causes 500 000 deaths annually1. Although colorectal 
cancer occurs mainly in Western and industrialized countries, since 1950 the incidence of this 
neoplasm has also increased in traditionally low-incidence regions. In United States, each citizen 
has a 6% lifetime risk of colorectal cancer, and, strikingly, this tumor is the second leading cause 
of cancer-related death after lung cancer. 
 
In 2005, 145 000 persons were diagnosed with and 56 000 individuals died of colorectal cancer 
in the United States. In some individuals with this malignancy, germ-line mutations are the 
readily identifiable cause. But in most, the development of cancer appears to be a complex 
interaction between the host genome and environmental factors. Advances in knowledge of 
colorectal cancer have resulted in improvements in surgical/endoscopic techniques, 
epidemiology, screening, and surveillance of high-risk groups. Several new chemotherapeutic 
agents have been developed as a result of our basic scientific understanding of tumor biology. 
Yet, despite these advances, surgery still remains the treatment offering the greatest hope for 
cure. Because colorectal cancer usually arises over a prolonged period and is accessible to 
screening techniques, secondary prevention remains the best way to decrease death from this 
malignancy, colorectal cancer is an important global health problem. In 2000, an estimated 944 
717 incident cases of colorectal cancer were diagnosed worldwide, with almost equal gender 
distribution: 498 754 cases in males and 445 963 in females50. Globally, about 500 000 
individuals die annually from this malignancy51. Worldwide, colorectal cancer is the third most 
commonly diagnosed malignancy after lung and breast cancer52. The incidence of this 
malignancy increases dramatically between 45 and 50 years of age, with 90% of cases occurring 
after the age of 50 years53,54. Consequently, deaths from colorectal cancer begin to increase 
slowly in the fifth decade of life, rising steeply with advancing age53,54, In general, the incidence 
of colorectal cancer continues to increase rapidly in countries with formerly a low risk 
(particularly Japan but also Asian countries). In high-risk countries, the trends are either 
gradually increasing or stabilizing (north and west Europe) or declining with time (North 
America). 
 
Geographical variation 
The occurrence of colorectal cancer varies greatly worldwide, with an almost 25-fold difference 
between specific populations. The highest annual incidence rates occur in Australia and New 
Zealand, followed by North America and Japan (75.8 to 85.1 per 100 000). Incidence tends to be 
lowest in middle, south central, and western Africa (5.8 to 8.6 per 100 000). In United States, the 
ratio of colon to rectal cancer is about 2:1, and in low-risk areas it is closer to 1:151 but in my 
study the incidence of rectal cancer is very high when compared to growth arising from rest of 
the colon. Incidence of CRC in India is 2 to 8 per 100,000. 
Anatomical trends  
Analysis of US colorectal cancer incidence data reveals that about 40% of malignancies occur in 
the right colon (cecum, ascending colon, hepatic flexure, and transverse colon), 31% in the left 
colon (splenic flexure, descending colon, and sigmoid colon), and 29% in the rectum. 
Etiology 
In a minority of cases, the occurrence of colorectal adenocarcinoma is directly attributable to a 
definable, usually inherited, molecular cause. However, in the vast majority of patients, this 
tumor results from a complex interaction between environmental factors and genetic 
predisposition  
Risk Factors for Colorectal Cancer 
(a) Age > 50 yr 
(b) High-fat, low-bulk diet 
(c) Personal history of Colorectal adenomas (synchronous or metachronous) 
(d) Family history of FAP, HNPCC, Polyposis syndromes: FAP, Gardner's syndrome, Turcot's 
syndrome, Muir-Torre syndrome, Peutz-Jeghers syndrome, familial juvenile polyposis, First-
degree relatives with colorectal cancer 
(e) Inflammatory bowel disease – Ulcerative colitis, Crohn’s Disease 
Table – 2 showed the various environmental risk factor for CRC 
Table - 2 
ENVIRONMENTAL RISK FACTORS IN THE CAUSATION OF CRC 
Risk factors  Increased risk (RRa) 
High red meat intake 1.5 – 3.6 
Obesity 2.0 
Cigarette smoking 1.9 
High calorie intake  1.7 
High fat intake 1.2 
Alcohol intake 1.4 – 1.7 
Protective factors  Decreased risk 
Physical activity 0.7 – 0.8 
High calcium intake 0.54 – 0.85 
Folate intake 0.25 – 0.66 
Selenium intake 0.58 
Estrogen/Progesterone 0.63 – 0.82 
NSAIDs 0.58 – 0.60 
Fiber intake 0.58 – 0.65 
Fruits and vegetable intake 0.48 
 CRC IN INDIA 
The incidence rates of both large and small bowel cancer are low in India,        and rectal cancer 
is more common than colon cancer. The incidence rates of colon cancer in eight population 
registries vary from 3.7 to 0.7/100,000 among men and 3 to 0.4/100,000 among women55. As per 
the  latest study conducted in Kasturba  Medical College, Manipal University, India56 on the 
effect of using combination chemotherapy in colorectal cancer in India: A single institute survey 
Incidence of cancer in male: female is 6.7:5.5 per 100, 000 population in India.   
Due to various reasons, the incidence of colorectal cancer is on increasing trend in India 
(Mohandas et al., 1999) For rectal cancer the incidence rates range from 5.5 to 1.6/100,000 
among men and 2.8 to 0/100,000 among women. One intriguing observation is the occurrence of 
rectal cancer in young Indians. Rural incidence rates for large bowel cancers in India are 
approximately half of urban rates. Immigrant studies reveal an increase in incidence as compared 
to the rates in native counterparts. Reliable time trends for India are available only from the 
Bombay registry. Significant increase in the incidence of colon cancer has been reported for both 
men and women over two decades, but the rates of rectal cancer are steady. The low incidence of 
large bowel cancers in Indians can be attributed to high intake of starch and the presence of 
natural antioxidants such as curcumin in Indian cooking. High rates of rectal cancers in young 
Indians could suggest a different etiopathogenesis, which is neither inherited nor traditional diet-
related. Incidence rates in India are quite low about 2 to 8 per 100,000. 
 
 
SCREENING FOR CRC  
Only one half of the average-risk population in the United States undergoes any  of the currently 
available screening tests for colorectal cancer, however57,  because of safety concerns, test 
invasiveness, inconvenience, costs,  embarrassment, and lack of education concerning colon 
cancer screening58. Cancer prevention is categorized into primary or secondary, primary 
prevention refers to the identification of genetic, biologic, and environmental factors that are 
etiologic or pathogenetic and subsequent alteration of their effects on tumor development. 
Although several areas of study have been identified that may lead to primary prevention of large 
bowel cancer, available data do not yet provide a firm basis for the practical application of 
primary preventive measures. The goal of secondary prevention is to identify existing 
preneoplastic and early neoplastic lesions and to treat them thoroughly and expeditiously. The 
assumption is that early detection improves prognosis.  
Results from randomized controlled clinical trials (RCT) have shown that with current 
technology, screening can greatly reduce colorectal cancer mortality and incidence59,60. 
 
Screening for CRC is broadly divided into  
1. Average risk,  
2. Increased risk,  
3. High risk.  
Various recommendations are available for screening including  
1. American cancer society 
2. US Preventive services task force 
3. Multidisciplinary Expert Panel 
 
Screening methods  
FOBT(Guaiac test and Immunoperoxidase method), FOS (Fiberoptic sigmoidoscopy), 
Colonoscopy, Double contrast Barium enema(DCBE). 
Other modalities available for evaluation of COLON/CRC Screening but not 
recommended by various societies like American cancer society etc.  
(a) Stool  DNA by PCR to detect mutations like K-ras, APC, p53 and BAT-26  
mutations.   
(b) CEA (Useful in the preop staging and postop follow-up of pts with large bowel cancer) 
(c) Capsule Endoscopy 
(d) Chromoendoscopy 
(e) Computed tomography (CT) colonography, or “virtual” colonoscopy 
(f) MR Colonography 
 
 
 
RECOMMENDATIONS FROM THE AMERICAN CANCER SOCIETY 
 
For Average risk individuals  
 
Beginning at age 50, men and women should follow one of these five testing schedules: 
Yearly fecal occult blood test (FOBT) or fecal immunochemical test (FIT) 
Flexible sigmoidoscopy every 5 years 
Yearly FOBT or FIT, plus flexible sigmoidoscopy every 5 years 
Double-contrast barium enema every 5 years 
Colonoscopy every 10 years 
All positive tests should be followed up with colonoscopy 
For increased risk individuals 
People with single, (<1 cm) 
adenoma 
3-6 yr after initial 
polypectomy Colonoscopy
If normal, patient can 
thereafter be screened as 
per guidelines for an 
average-risk person 
People with a large (≥1 cm) 
adenoma, multiple adenomas, 
or adenomas with high-grade 
dysplasia or villous change 
Within 3 yr after initial 
polypectomy Colonoscopy
If normal, repeat 
examination in 3 yr; if 
normal, the patient can 
thereafter be screened as 
per average risk 
guidelines 
Personal history of curative-
intent resection of colorectal 
cancer 
Within 1 yr after cancer 
resection Colonoscopy
If normal, repeat 
examination in 3 yr; if 
normal, repeat 
examination q 5 yr 
Either colorectal cancer or 
adenomatous polyps in any 
first-degree relative before age 
60 yr, or in ≥2 first-degree 
relatives at any age (if not a 
hereditary syndrome) 
Age 40 yr, or 10 yr 
before the age of the 
youngest case in the 
immediate family 
(whichever is sooner) Colonoscopy Every 5-10 yr 
 
 
 For High Risk Individuals 
Family H/O FAP Puberty 
Surveillance with 
FOS, & 
counseling to 
consider genetic 
testing 
If genetic testing +ve, 
colectomy is indicated 
and refer the pt. to center 
with experience in FAP 
Rx 
Family history of HNPCC Age 22 yrs 
Colonoscopy & 
genetic testing 
If the genetic testing is 
+ve or not done q 1-2yrs 
until age 40 yrs.then 
annually, these pts are 
better referred to centre 
with experience in 
HNPCC Rx 
IBD (UC, Crohns) 
Cancer risk become 
significant 8 yrs 
after Pancolitis, 10-
15 yrs after left 
sided colitis 
Colonoscopy with 
Bx for dysplasia  
Every 1-2yrs. Then pts. 
Referred to center with 
experience in IBD 
survilence and Tx 
Either colorectal cancer or 
adenomatous polyps in any 
first-degree relative before 
age 60 yr, or in ≥2 first-
degree relatives at any age 
(if not a hereditary 
syndrome) 
Age 40 yr, or 10 yr 
before the age of the 
youngest case in the 
immediate family 
(whichever is 
sooner) Colonoscopy 
Every 5-10 yr; colorectal 
cancer in relatives more 
distant than first-degree 
does not increase risk 
substantially above the 
average-risk group 
 
 
 
 
 
 
 
 
 
 
STAGING OF CRC 
 AJCC TNM Staging of Colorectal Cancer 
Stage Criteria 
0 Carcinoma in situ: intraepithelial or invasion of lamina propria (Tis N0 M0) 
I Tumor invades submucosa (T1 N0 M0)—Dukes A 
Tumor invades muscularis propria (T2 N0 M0) 
II Tumor invades through the muscularis propria into subserosa or into nonperitonealized 
pericolic or perirectal tissues (T3 N0 M0)—Dukes B 
Tumor perforates the visceral peritoneum or directly invades other organs or structures 
and/or perforates visceral peritoneum (T4 N0 M0) 
III Any degree of bowel wall perforation with regional lymph node metastasis 
N1: metastasis in 1-3 regional lymph nodes 
N2: metastasis in ≥4 regional lymph nodes 
Any T N1 M0—Dukes C 
Any T N2 M0 
IV Any invasion of bowel wall with or without lymph node metastasis, but with evidence of 
distant metastasis 
Any T 
Any N M1 
 
Usually we do CECT Abdomen for staging colorectal malignancy but while 
subjecting the patient for MRC/MRI Abdomen, staging of colorectal malignancy 
is very accurate especially for staging carcinoma rectum. 
  
INFLAMMATORY BOWEL DISEASE – ROLE OF COLONOSCOPY AND 
MRC 
 
Patients, who have chronic IBD, whether classified as ulcerative colitis or Crohn’s colitis, are at 
greater than average risk of developing CRC61. A recent meta-analysis of 116 studies found the 
overall prevalence of CRC in ulcerative colitis to be 3%, with a cumulative risk of CRC of 2% at 
10 years, 8% at 20 years, and 18% at 30 years62 
There also is considerable geographic variation, with higher rates of cancer in the United States 
and United Kingdom and lower rates in Scandinavia 62.  
The mean time from the diagnosis of colitis to the diagnosis of cancer is 17 years, with a mean 
age at diagnosis of cancer of 51 years for men and 54 for women63. One study suggested that 
colon cancer accounts for one third of deaths in ulcerative colitis64, whereas another study found 
that this cancer accounts for only one sixth of deaths65. 
Both Crohn’s colitis and Ulcerative colitis  tend to have cancer diagnosed after eight years of 
IBD and frequently have multifocal cancer with an aggressive (signet ring or mucinous) 
histology. 
The precise pathogenesis of CRC in IBD is unclear. The pathogenesis is believed to involve 
chronic inflammation leading to increased cell proliferation with subsequent development of 
dysplasia66,67. 
Colonoscopic surveillance to prevent colon cancer in IBD is based on the concept of stepwise 
progression from chronic inflammation through low-grade dysplasia (LGD) and high-grade 
dysplasia to cancer. 
 Risk factors for CRC in patients who have IBD  
 
(1) Duration of disease 
(2)Extent of colitis 
(3)Primary sclerosing cholangitis 
(4)Family history of CRC 
(5)Inflammatory pseudopolyps 
(6)Degree of histologic inflammation 
 
The coexistence of primary sclerosing cholangitis (PSC) confers an approximately fivefold 
increase in CRCrisk68 - 71. In IBD-related cancers, however, the precursor dysplastic lesion often 
is flat and may not be readily evident endoscopically. Thus, the primary strategy for preventing 
CRC in patients who have IBD is surveillance colonoscopy with multiple random biopsies 
throughout the colon to detect dysplasia, with subsequent proctocolectomy for patients harboring 
dysplastic lesions in the hopes of preventing progression to cancer or of removing cancer at an 
earlier, potentially curable, stage. 
Despite the lack of conclusive evidence of benefit, surveillance colonoscopy with biopsy 
currently is recommended by the major gastrointestinal societies worldwide, including the 
American Gastroenterology Association, the American Society for Gastrointestinal Endoscopy, 
and the American College of Gastroenterology. 
The recommendation is that screening should begin 8–10 years after the onset of symptoms in 
patients with pancolitis or left-sided colitis. Surveillance should be repeated at 1- to 2-year 
intervals. For patients with only proctosigmoiditis the risk of colon cancer is considerably lower 
than that for patients with left-sided disease or pancolitis and in this population the 
recommendation for colon cancer screening is the same as for the general population. 
 
For patients who have ulcerative colitis and primary sclerosing cholangitis there is a markedly 
increased risk of colon cancer compared with patients who have ulcerative colitis alone and 
yearly colonoscopic examinations are recommended beginning as soon as the diagnosis of 
primary sclerosing cholangitis is made. The consensus recommendations for surveillance 
colonoscopy include four-quadrant biopsies taken every 10 cm, beginning at the proximal extent 
of disease. 
 
Guidelines have been developed for decision-making based on the results of the surveillance 
biopsies72. A patient with low-grade or high-grade dysplasia found in a discrete adenoma-like 
polyp, but nowhere else, can be safely managed with polypectomy and accelerated surveillance. 
When a polyp is removed, separate biopsies should be taken from the flat areas around the base 
of the polyp. If dysplasia is found in the area around the polyp then colectomy is recommended 
because of the high association with synchronous cancer. Dysplasia of any grade found in an 
endoscopically unresectable polyp or high-grade dysplasia found in flat mucosa are both strong 
indications for proctocolectomy. 
High-grade dysplasia in a flat area is associated with a high risk of synchronous colorectal cancer 
elsewhere in the colon and a colectomy is recommended. 
The management of low-grade dysplasia found in flat mucosa is controversial. Some 
investigators recommend colectomy whereas others recommend repeat colonoscopy within 6 
months. 
In a review of 10 surveillance studies low-grade dysplasia was associated with synchronous 
cancer in 19% of patients73. In patients who were followed after a diagnosis of low-grade 
dysplasia a significant number (16%– 29%) progressed to high-grade dysplasia, dysplasia-
associated lesion or mass, or cancer. 
 
A Comparison of MRI Colonography with Conventional Colonoscopy for the Assessment of 
Intestinal Inflammation in Patients with Inflammatory Bowel Disease74 by Andreas shreyer MD, 
RSNA December 2004. In patients with UC and CD sever inflammation, pseudopolyps and 
complications like strictures are diagnosed by MRC but in most cases mild inflammation were 
not diagnosed by MRI. 
 
COLONOSCOPY AND MRC IN IBD 
 
MRC has no role in IBD either diagnosis or follow-up, but it has a role if the patent develops 
stricture/narrowing due to Crohn’s disease.   
 
ROLE OF COLONOSCOPY AND MRC IN COLONIC POLYPS 
Colonic polyps are divided into two major groups:  
Neoplastic (the adenomas and carcinomas) and Non-neoplastic.  
Adenomas and carcinomas share a common characteristic—cellular dysplasia—but they may be 
subdivided according to the relative contribution of certain microscopic features.  
The non-neoplastic polyps may be grouped into several distinct categories, including 
hyperplastic polyps, “mucosal polyps,” juvenile polyps, inflammatory polyps, and others. 
Submucosal lesions also may impart a polypoid appearance to the overlying mucosa and 
therefore are briefly mentioned even though they are not true polyps. 
Adenomas are categorized into three size groups: <1 cm, 1 to 2 cm, and >2 cm.75 Overall, most 
adenomas are smaller than 1 cm, but the size distribution of adenomas may vary greatly among 
studies, depending on study design, age of the study population, and location of the adenomas 
within the colon.  
Adenoma size increases as a function of age,76,77,78 even in low-prevalence countries,79 and larger 
adenomas are more common in distal colonic segments.75,80,81  
Diminutive polyps measure 5 mm or less in diameter and are commonly encountered during 
endoscopy. An earlier concept that these lesions were almost always non-neoplastic has been 
revised based on several flexible sigmoidoscopic and colonoscopic studies in which 30% to 50% 
of diminutive polyps were found to be adenomatous 
 
Flat Adenomas. 
Macroscopically, a flat adenoma is either completely flat or slightly raised and may contain a 
central depression. Typically less than 1 cm in diameter, these lesions can be missed easily at 
endoscopy. This potential risk has prompted investigators, particularly in Japan, to adapt better 
methods of detection that involve the use of dye-spraying (chromoendoscopy) to generate a 
contrast relief-map image of the mucosa, or magnification colonoscopy, for enhanced 
visualization.82 In studies without the use of such specialized endoscopic techniques, flat 
adenomas accounted for 8.5% to 12% of all adenomas and could be multiple.83,84   
Serrated adenomas are polyps that share features of both adenomatous and hyperplastic polyps 
 
Anatomic Distribution 
The distribution of adenomatous polyps within the colon differs, depending on the method of 
investigation. In autopsy series, adenomas are distributed uniformly throughout the colorectum; 
this even distribution has been confirmed in colonoscopic investigations of asymptomatic 
subjects.85,86. Large adenomas in autopsy series have a distal predominance, in the region where 
most colon cancers arise, thereby supporting the adenoma-carcinoma hypothesis. Adenomas 
detected in surgical and colonoscopic studies of symptomatic people also display a left-sided 
predominance. In older individuals, those older than 60 years of age, adenoma distribution 
demonstrates a shift toward more proximal colonic locations. 
Investigations 
Colonoscopy is the gold standard for evaluation of colonic polyps, however for screening in 
asymptomatic individuals other non-invasive modality like MR Colonography and CT 
Colonography is preferable for initial assessment, once polyp has been confirmed by MRC it is 
better to subject the patient for colonoscopy and biopsy in order to plan further management. 
Flat adenomas are missed even during routine colonoscopy evaluation, in those individuals other 
advanced modalities like Chromoendoscopy, and Narrow band imaging is preferable   
 OTHER ADVANCED IMAGING MODALITY 
Chromoendoscopy:  
Chromoendoscopy, or chromoscopy, refers to the topical application of stains or dyes at the time 
of endoscopy in an effort to enhance tissue characterization, differentiation, or diagnosis. The 
stains that are used for chromoendoscopy are classified as absorptive (or vital), contrast, or 
reactive. Absorptive stains, such as Lugol’s solution and methylene blue, identify specific 
epithelial cell types by preferential absorption or diffusion across the cell membrane.  
Contrast stains, such as indigo carmine, seep through mucosal crevices and highlight surface 
topography and mucosal irregularities. Reactive stains, such as congo red and phenol red, 
undergo chemical reactions with specific cellular constituents, resulting in a color change akin to 
a pH indicator. 
 
Magnification endoscopy  
Magnification endoscopy is often used to provide higher resolution images of the epithelium in 
concert with Chromoendoscopy. Most videoendoscopes provide optional magnified or “zoom” 
imaging. The most obvious application of this relatively simple technique is in the detection of 
duodenal villous atrophy. It also play a role in the evaluation of colonic lesions. 
Narrow band imaging (NBI)  
Narrow band imaging (NBI) involves the use of interference filters to illuminate a target in 
narrowed red, green and blue (R/G/B) bands of the spectrum. The imaging modality is built into 
commercial endoscopy processors and no catheters or probes are necessary. NBI provides 
imaging of the surface of epithelium, particularly of the surface vascular pattern. Many early 
malignancies have surface pattern changes in vascularity, such as the corkscrew pattern seen in 
early gastric cancer87. When NBI is used in conjunction with magnification endoscopy, the 
diagnosis of metaplasia, dysplasia and cancer of the upper and lower GI tract can be secured with 
a high degree of accuracy88. In comparative trials, NBI has produced results similar to high-
resolution Chromoendoscopy 89. 
Endoscopic confocal microscopy  
Endoscopic confocal microscopy provides the highest resolution images of the GI tract of any 
imaging modality90. The instrument is a dedicated endoscope with an independent processor and 
is not yet widely available. Confocal endomicroscopy uses blue laser light and is often used in 
conjunction with an intravenous and a topical fluorescent agent. The images obtained from this 
technique provide near real-time cellular details, including individual epithelial cells to a depth 
of 1–2 mm. The crypts of the colonic mucosa, the villi of the terminal ileum and duodenum, the 
gastric pits of the stomach, and the squamous epithelium of the distal esophagus can be clearly 
visualized. The technique has been demonstrated to improve the detection of dysplasia arising 
from the colonic mucosa in patients with inflammatory bowel disease91.  
Among the advanced imaging modalities Chromoendoscopy and NBI is available in some 
centers. It is very helpful especially in the evaluation of colon in following situations like. 
To take targeted biopsy in patients with IBD on regular follow up to ruled out malignancy and to 
rule out malignant transformation of polyps and adenomas. 
 
 
 
  
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
 
 
 
Materials and Methods 
This comparative study between Colonoscopy and MR Colonography was carried out in the 
Department of medical Gastroenterology and Radiology Department of Madras Medical College, 
Chennai. This is the major referral tertiary care center available to the entire Tamilnadu, 
Pondicherry and neighboring states like Andhra Pradesh and Karnataka.  
The study was carried between the February 2008 to January 2010. (24 months) 
Patients who are attending Medical Gastroenterology Department with clinical diagnosis highly 
suspicious of colorectal pathology were included in this study.  
Sixty patients were taken up for study and out of sixty patients thirty patients underwent 
colonoscopy first then subjected to  MR Colonography and another thirty patients were 
subjected for MR Colonography first then followed by Colonoscopy. 
Inclusion Criteria 
Patients with bleeding per rectum suggestive of colonic lesion rather than perianal problem like 
hemorrhoids or fissure  
Significant weight loss & Change in bowel habits with Positive FOBT 
Abnormal finding during rectal examination 
Patients with family history of Colorectal Cancer/ Polyposis with symptoms of bowel disease.  
 
CURRENT ACCEPTED INDICATIONS FOR MR COLONOGRAPHY 
(1) Incomplete colonoscopy because an obstructing mass or stricture prevented examination of 
the proximal colon 
(2) Incomplete colonoscopy because of colonic tortuosity, adhesions, severe diverticular disease, 
or patient intolerance of colonoscopy 
(3) Inability to perform colonoscopy because of a strong requirement for anticoagulant therapy 
or risks of sedation 
(4) Patients who have a strong indication for diagnostic colonoscopy but who adamantly refuse 
to undergo colonoscopy.  
We have extrapolated the recommendations given for CT Colonography to MRC, since both the 
modality is technically same with the advantage of no radiation for MRC. 
Exclusion criteria  
Patients with metal implants like Hip prosthesis, cardiac pacemaker and intracranial aneurismal 
coil were excluded from MR Colonography 
RELATIVE CONTRAINDICATION FOR MRC 
(1) Severe allergy to administered contrast (MRC can be performed without contrast) 
(2) Suspected colonic perforation or peritonitis 
(3) Walled off colonic leak/pericolonic abscess 
(4) Medically highly unstable patient (eg, unstable angina, uncontrolled sepsis) 
(5) Acute lower gastrointestinal bleeding 
(6) Pregnancy 
(7) Inability to tolerate pneumocolon/water instillation  
(8) Highly uncooperative patient 
(9)Inability to undergo colonic preparation: congestive heart failure, severe electrolyte 
imbalances, severe dehydration 
(10) Refusal to undergo colonic preparation 
(11) Abnormal anorectal anatomy (eg, imperforate anus, tight anal stricture) 
(12) Severe colonic disease (toxic colitis, toxic megacolon, severe colonic pseudo obstruction) 
(13) Acute colonic infection (acute diverticulitis, severe infectious colitis) 
(14) Complete mechanical colonic obstruction 
(15) Very recent colonic surgery (<1 week) 
Hip prostheses, which generally are not considered a contraindication to MR imaging, can result 
in considerable artifacts in the pelvis, thereby impeding acquisition of an image of the sigmoid 
colon and rectum that has adequate diagnostic quality 
Study protocol 
Patients attending medical gastroenterology outpatient department referred from various 
departments with history suggestive of large bowel pathology were included in the study. Their 
name clinical history, examination and investigation were entered in the proforma (Annexure). 
Patients with history and examination suggestive of organic problem alone were included in the 
study; those patients with history suggestive of Functional Bowel Disorders were excluded. Most 
of the patients were admitted in our ward and the rest of the patient was taken up for study from 
the respective wards.  
 
 
Patient preparation 
Most of the patients were prepared by giving Polyethylene Glycol colonic Lavage (Peglec net 
weight: 137.9 gms mixed  with 2L of plain water gives Polyethylene glycol- 18meq/L, Sodium -
125meq/L, Potassium-10meq/L Chloride-35meq/L, Sulphate-80meq/L, Bicarbonate-20meq/L) 
250ml of peglec solution given per orally every 15minutes. Usually first bowel movement occurs 
one hour after administration of peglec preparation, and then evacuation occurs several times, 
keep administering peglec until the rectal effluent is clear. Lavage is usually complete after the 
intake of 1.5-2L. 
Patients with suspected bowel obstruction and rectal lesion were prepared by doing bowel wash 
with plain water until the wash become clear. Both colonoscopy and MRC procedure and the 
risks associated were explained in detail and informed consent was obtained from the patients 
(ANNEXURE). The patients were kept in only liquid diet from the previous night. Basic 
investigations (Blood and ECG) done for all the patients prior to procedure. 
Equipment  
Video Colonoscope – Pentax EC 3830/EC 3801L, 168 cm in length.  
 Light source and Image processor – EPM - 3300 
 
1.5 Tesla MRI in Department of Radiology, Madras medical college. 
 
 
Technique  
After preparing the patient adequately thirty patients were taken up for colonoscopy first then 
MRC and the other thirty patients were taken up for MRC first then colonoscopy.  
We do colonoscopy in our endoscopy suite regularly without anesthesia however for 
uncooperative patients and patients with intolerable pain related to procedure we give mild 
sedation like Inj. Promethazine 25 mgm or Inj.Midazolam 2.5-7.5 mgm. After putting the patient 
in left lateral position Rectal examination done then with adequate application of Lignocain gel 
over the distal end of the scope, colonoscope introduced into the rectum and by changing the 
patient position according to the site of scope tip, the procedure was done and  one staff nurse  
assisted throughout the procedure. 
MR COLONGRAPHY 
Before starting the procedure, 20mg of Hyoscine was given IV to reduce peristalsis/spasm. After 
positioning the patient in Lithotomy position, Foleys catheter introduced  into the rectum, 1.5 to 
2.0 liter of plain water introduced into the rectum at the rate of 120ml/mt with IV administration 
of paramagnetic contrast gadolinium for enhancement of colonic lesions in case of dark lumen 
MRC. The lesion appears as hypeintense in dark lumen MRC.  Diluted gadolinium is instilled 
into the rectum in case of bright lumen MRC.  
MRC is performed from the level of the diaphragm to the level of the perineum. Images are 
obtained in both the supine and prone positions to  
(1) Differentiate particulate stool from fixed lesions such as polyps or cancers 
(2) Distend adequately colonic regions poorly distended in one position because the air is 
redistributed with a change in patient position 
(3) Evaluate adequately colonic regions obscured by residual fluid because fluid is redistributed 
with a change in patient position. The optimal scanning technique should minimize scanning 
time, and maximize image quality. 
We use to do MRC by using two techniques like Bright lumen MRC and dark lumen MRC. 
Bright lumen MRC 
With “bright lumen” MRC colorectal lesions are visualized as dark filling defects within the 
bright colonic lumen. This can be achieved by administering a rectal enema containing 
paramagnetic contrast. On 3D gradient echo data sets only the contrast-containing colonic lumen 
is bright whereas the surrounding tissues including colonic wall and polyps and other lesions 
remain low in signal intensity. A new approach for “bright lumen” MRC is based on the 
acquisition of True FISP (fast imaging with steady-state precession) sequences. Using a rectal 
water-enema, the contrast mechanism is comparable to that of the approach in conjunction with a 
paramagnetic contrast enema and the acquisition of T1w GRE sequences. Since the True FISP 
technique neither requires the administration of intravenous nor rectal paramagnetic contrast 
medium and it appears economically attractive. The detection of colorectal lesions with “bright 
lumen” MRC relies on the visualization of filling defects. Differential considerations for such a 
filling defect beyond polyps include air bubbles as well as residual fecal material. To permit 
differentiation datasets are collected in both the prone and supine patient position: air and fecal 
material move, while polyps remain stationary. While effective in most instances, the technique 
can introduce errors. Thus, polyps with a long stalk may move sufficiently to impress as a 
moving air bubble or more probably residual stool, while stool adherent to the colonic wall may 
not move at all and, thus, falsely impress as a polyp. 
Dark lumen MRC 
In addition to obviating the need for the time consuming 3D data acquisition “dark lumen” 
MRC92 facilitates the identification of polyps and other lesions with in shorter period of time 
when compared to bright lumen technique. “Dark lumen” MRC focuses on the colonic wall. It is 
based on the contrast generated between a brightly enhancing colonic wall and a homogeneously 
dark colonic lumen. The technique differs from “bright lumen” MRC in the following manner: 
(a) Instead of gadolinium containing enema only tap water is rectally applied rendering low 
signal on heavily T1weighted 3D GRE (Gradient echo) acquisitions. 
(b) The colonic filling process is monitored with a fluoroscopic T2w sequence, rather than a T1w 
sequence. 
To obtain a bright colonic wall paramagnetic contrast (Gadolinium based contrast agents like 
Gadopentetic acid (Magnevist) dose 0.1 mmol/kg) was given intravenously. 3D datasets are 
collected before the application and after a 75 second delay. 
As residual air exhibits no signal in the colonic lumen, the examination needs to be performed 
only in the prone patient position. Furthermore, the “dark lumen” technique copes with the 
problem of residual stool in a simple manner: if the lesion enhances, it is a polyp or growth; if it 
does not enhance, it represents stool. While most mass lesions smaller than 5 mm in size were 
missed, almost all lesions exceeding 8mm were correctly identified. MRC identified additional 
lesions in regions of the colon not reached by colonoscopy in situation like obstructing type of 
rectal growth.Table – 3 showed the comparison of various MRC techniques  
Aftercare 
Patients underwent procedure without sedation and were asked to eat immediately after 
MRC/Colonoscopy. But if the procedure done under sedation the patient was allowed to take 
food only after 6 hours. 
TABLE - 3 
MRC - VARIOUS TECHNIQUES COMPARISSION 
Parameters Bright lumen Black lumen Fecal tagging 
Bowel cleansing Yes Yes  No 
Diet with barium No No Yes 
Enema  Gado in water Water  Water  
Filling sequence 2D GRE 2D Balanced GRE 
or T2 
2D Balanced GRE 
Enhancement with 
dynamic scanning 
No Yes Yes  
Combination bright 
black lumen 
NA With 3D balanced 
GRE sequence 
NA 
Cost factor Costly  Relatively Cheap  Relatively Cheap  
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Results 
Baseline characteristics 
Sixty patients who fulfilled the study criteria were included in the present study.  
The mean age was 47 years and the male female ratio of   (M: F) 37: 23 (2: 1) (Fig-1) 
Baseline characteristics of patients selected for study 
Age in years (Median) - 47 years (Fig-2) 
TABLE - 4 
 
No  Age of the patients No of patients (N-60) 
1 50 years and above 27 
2 40 – 49 years 13 
3 30 – 39 years 13 
4 <30 years 07 
 
CLINICAL FEATURES AT PRESENTATION 
Patients with clinical history and examination highly suggestive of organic lesions like bleeding 
PR, motion for occult blood positive and mass palpable per abdomen or growth rectum in PR 
examination only were included. Patients with history suggestive of functional bowel disorders 
were not included in this study. 
Out of sixty patients nineteen patients presented with bleeding per rectum, thirteen patients 
presented with growth rectum on rectal examination and significant overlap of bleeding PR and 
growth rectum was seen. Six patients were diagnosed as IBD-UC, Seven patients diagnosed as 
TB abdomen, two patients diagnosed as rectal polyp, five patients with secondaries liver to rule 
out colonic lesions, FOBT positive in fifteen patients with suspected carcinoma colon and 
palpable RIF mass in one patient and diarrhea in one patient. (Table-5 and Figure-3) 
TABLE - 5 
Clinical features (History and Examination) with FOBT at presentation 
No  Clinical features at presentation No of pts. 
01 Bleeding per rectum 19 
02 FOBT Positive 15 
03 Growth Rectum 13 
04 TB Abdomen 07 
05 IBD – UC 06 
06 Secondaries Liver 02 
07 ? Growth Colon 03 
08 Rectal polyp 02 
09 RIF Mass 01 
10 Chronic diarrhea  01 
11 Anemia 01 
 
Based on the above clinical/examination findings patients were subjected for Colonoscopy and 
MRC. Thirty patients were subjected first to colonoscopy followed by MRC and another thirty 
patients were subjected for MRC first then colonoscopy. 
After adequate bowel preparation as discussed already colonoscopy done  
 
 
COLONOSCOPY - Scope passed up to: (Fig - 4) 
Ileum/Cecum               - 42 Patients 
Ascending colon - 05 Patients (5 Obstructing growth) 
Hepatic flexure - 01 Patients (1 Obstructing growth) 
Transverse colon - 01 Patients (1 Intussuscepting growth) 
Splenic flexure - 01 Patients (1 Poor pt. tolerance) 
Descending colon - 01 Patients (1 Obstructing growth) 
Sigmoid   - 03 Patients (stricture 1 + obst.growth 1 + poor tolerance 1) 
Rectum   - 06 Patients (6 Obstructing growth) 
 
Out of sixty patient’s colonoscopy passed up to cecum/ileum in forty-two patients, which 
accounts for 70%. In the remaining eighteen patients (30%) scope not passed up to cecum due to 
following reasons. 
Scopes passed only up to mid-ascending colon in five patients due obstructing lesion were 
further scope negotiation not possible. 
Scope passed up to hepatic flexure in one patient due to obstructing lesion 
Scope passed up to mid transverse colon in one patient due to intussuscepting lesion 
In one patient scope passed only up to splenic flexure due to poor tolerance 
In one patient scope passed only up to descending colon due to obstructing lesion 
Among ten patients with Growth Rectum, scope negotiation beyond the lesion was not possible 
in six patients due to obstructing growth. 
Scope negotiation beyond sigmoid was not possible in three patients due to narrowing by 
stricture in one patient, obstructing growth rectosigmoid in one patient and patient intolerant to 
procedure in one. 
Out of sixty, in eighteen patients complete examination of colon was not possible due to the 
reasons mentioned above, and among this obstructing lesion accounts for sixteen patients and 
patient intolerance account for two patients. 
 On the same day after colonoscopy MRC done in radiology department and in those patients 
subjected for MRC first, they underwent colonoscopy on next day. Both the findings are 
tabulated and compared to find out the merits and demerits of each modality and to find out the 
Sensitivity, Specificity, Positive predictive value and Negative predictive value of MRC in 
comparison with standard tool Colonoscopy. 
 
 
 
 
 
 
 
 
TABLE - 6 
INTERPRETATION OF COLONOSCOPY AND MR COLONOGRAPHY 
NO TYPE OF LESION BY COLONOSCOPY BY MRC 
1 Growth rectum 10 10 
2 Growth Rectosigmoid 03 03 
3 Growth Descending colon 01 01 
4 Growth transverse colon 02 02 
5 Growth ascending colon 04 05 
6 Proctitis 03 0 
7 Proctosigmoiditis 04 2 normal and 2 
thickened rectum 
8 Left sided colitis 01 0 
9 Rad. Proctosigmoiditis + stricture 01 Sigmo  narrowing 
10 Pancolitis  03 2 thicken RS & 1 
normal 
11 Ileocecal TB 04 3 Thicken cecum & 1 
normal  
12 Ileocecal Crohn’s 02 0 
13 Colonic polyps including FAP(2) & 
Solitary polyp 
8 Polyp + 2 FAP 10 with additional 
findings 
14 Solitary rectal ulcer 01 0 
15 Sig diverticulosis with fistula 01 Only diverticulosis 
16 Normal study  10 10 
 
DIAGNOSTIC ACCURACY OF COLONOSCOPY AND MRC 
From the above Table – 6 by comparing colonoscopy and MRC, diagnostic accuracy for the 
Growth arising from rectum, rectosigmoid, descending colon, transverse colon and ascending 
colon is same. However one patient with obstructing growth rectum showed thickened ascending 
colon suggestive of? Synchronous lesion in ascending colon by MRC.  One patient with post 
radiation Proctosigmoiditis and stricture in sigmoid colon by colonoscopy were reported as only 
narrowing of sigmoid? Stricture by MRC.  
Four cases of suspected Ileocecal TB by colonoscopy (Fig-9) were reported as thickened wall of 
cecum in three patients and normal study in one patient by MRC.  
One patient with sigmoid diverticulosis and low rectal fistula by colonoscopy were reported as 
diverticulosis by MRC and the fistula was not demonstrable. 
Three cases of Proctitis, one left sided colitis and two Ileocecal Crohn’s and one solitary rectal 
ulcer diagnosed by colonoscopy were reported as normal by MRC. (Table-7)  
Among four cases of Proctosigmoiditis by colonoscopy two were reported as normal and the 
other two cases were reported as thickened wall of rectum? Significant by MRC.  
Three cases of IBD – UC Pancolitis by colonoscopy were reported by MRC as normal study in 
one patient and thickened wall of rectosigmoid in two patient. (Table-7) 
 
 
 
 
 
TABLE - 7 
COLONOSCOPY AND MRC IN IBD 
No Colonoscopy findings MRC findings 
1 Proctitis  in 3 patients  Normal study in 3 pts 
2 Proctosigmoiditis in 4 patients  2 normal and 2 thickened 
rectum ?significant  
3 Left sided colitis in 1 patient Normal in that 1 patient 
4 Pancolitis in 3 patients 2 thickened rectosigmoid ? 
significant & 1 normal 
5 Ileocecal crohn’s in 2 patients  Normal study of 2 pts 
 
COLONOSCOPY AND BIOPSY 
Biopsy done for all patients with lesion (growth/inflammation) during colonoscopy examination. 
Out of thirteen patients with growth rectum biopsy showed Adenocarcinoma in all of them. 
Biopsy taken from five patients with growth ascending colon revealed Adenocarcinoma in three 
patients and non specific inflammatory infiltrate in two patients, but the repeat biopsy was 
positive for malignancy. 
Two patients with growth transverse colon revealed Adenocarcinoma in both patients. 
Biopsy taken from eight patients with colorectal polyp showed hyperplastic polyp in two patients 
adenomatous polyp in three patients and inflammatory cell infiltrate in three patients. 
Two patients diagnosed as Familial Adenomatous Polyposis (FAP) (Fig-7). showed 
adenomatous polyp (one patient tubular adenoma and other one tubulovillous) in biopsy (Fig-10)  
Twelve patients with inflammatory disorder of the colon like Proctitis, Proctosigmoiditis,  Left 
sided colitis and pancolitis showed varying inflammatory cell infiltrate (No evidence of dysplasia 
in all patients) 
Biopsy done in four patients with suspected Ileocecal TB revealed Non-specific inflammation in 
two patients and caseating granulomas in two patients. 
Biopsy taken from suspected Ileocecal Crohn’s showed non-specific inflammation in one patient 
and non-caseating granulomas in one patient. 
 
COLONOSCOPY AND POLYPECTOMY 
Out of eight patients with colorectal polyp, polypectomy done for five patients and another three 
patients did not report for polypectomy. 
 
ADDITIONAL FINDINGS BY MRC WHEN COMPARED TO 
COLONOSCOPY 
(a) In one patient with growth mid-descending colon with luminal narrowing, scope not passable 
beyond the obstructing lesion, the MRC showed a polypoid lesion in splenic flexure in addition 
to growth. (Table - 8) 
(b)In another patient colonoscopy passed only up to splenic flexure due to poor patient tolerance, 
showed a polyp in sigmoid colon; however MRC showed another polypoid lesion in ascending 
colon. 
(c)Three patients with obstructing growth rectum where scope not passable beyond the lesion 
(Fig-8) subjected for MRC showed thickened wall of ascending colon in one patient and 
thickened wall of descending colon in one patient suggestive of? Synchronous lesions and 
polypoid lesion in descending colon in another patient. 
TABLE - 8 
ADDITIONAL FINDINGS WITH MRC 
No  Type of lesion Colonoscopy MRC 
1 Growth  descending 
colon 
Growth mid 
descending colon 
Growth mid descending colon with 
polypoid lesion in splenic flexure 
2 Sigmoid polyp Sigmoid polyp Sigmoid polyp with another polyp in 
ascending colon 
3 Growth rectum Growth rectum Growth rectum with thickened wall of 
ascending colon? Synchronous lesion 
4 Growth rectum Growth rectum Growth rectum with thickened wall of 
descending coon? Synchronous lesion 
5 Growth rectum Growth rectum Growth rectum with polypoid lesion in 
descending colon 
 
EXTRACOLONIC FINDINGS ON MR COLONOGRAPHY 
Among ten patients with Growth rectum diagnosed by MRC, three patients showed pelvic nodal 
involvement and one patient showed liver metastasis (Fig-6). Among two patients with growth 
transverse colon (growth transverse colon + growth proximal transverse colon and hepatic 
flexure) and five patients with growth ascending colon one patient in each showed liver 
metastasis. In addition to liver metastasis one patient with ascending colon growth also showed 
cholelithiasis. One patient with Proctitis showed left renal calculi with cholelithiasis but normal 
study of colonic lumen by MRC. One patient with radiation Proctosigmoiditis with stricture 
showed sigmoid narrowing with left sided hydrouretronephrosis by MRC. (Table-9) 
 
TABLE - 9 
EXTRACOLONIC FINDINGS ON MR COLONOGRAPHY 
 
No Colonoscopy MRC – Colon findings Extracolonic findings 
1 Growth rectum (n-10) Growth rectum  Pelvic nodes with liver 
mets 
2 Growth rectum (n-10) Growth rectum  Pelvic nodes 
3 Growth rectosigmoid (n-3) Growth rectum   Pelvic nodes 
4 Growth Transverse colon(n-2) Growth Transverse colon Liver mets 
5 Growth ascending colon (n-5) Growth ascending colon  Liver mets with Gallstones 
6 Proctitis (n-1) Normal study  Left renal calculi with 
Gallstones 
7 Radiation proctosigmoiditis 
with stricture at sigmoid (n-1) 
Sigmoid narrowing Left sided 
Hydrouretronephrosis 
 
MRC WITH MRI FOR STAGING GROWTH RECTUM 
As a routine we did MRI Abdomen and Pelvis in all patients subjected for MRC, which was very 
useful for staging purpose. As per latest recommendation High spatial resolution 3 Tesla MRI is 
very accurate in determining the Mesorectal fascia involvement, which is very helpful for 
surgeons in planning circumferential resection. In addition to detection of Mesorectal fascia 
involvement T2 W thin section MRI abdomen also detects peritoneal infiltration and extramural 
rectal involvement. 
3 Tesla MRI is highly sensitive and ideal for staging growth rectum, but in our institution we 
have only 1.5 Tesla MRI, using this we did routine staging of rectal cancer. Out of 13 patients 
with growth rectum 5 patients  underwent CT Abdomen already, as suggested by their respective 
ward medical officer, but while comparing the diagnostic and staging accuracy of  CT Abdomen 
and 1.5 Tesla MRI Abdomen, both modalities diagnostic accuracy was same. 
STATISTICS 
MRC * Colonoscopy Crosstabulation
24 5 29
40.0% 8.3% 48.3%
21 10 31
35.0% 16.7% 51.7%
45 15 60
75.0% 25.0% 100.0%
Count
% of Total
Count
% of Total
Count
% of Total
Positive
Negative
MRC
Total
Positive Negative
Colonoscopy
Total
 
 
Based on the above findings when comparing MRC with gold standard 
Colonoscopy: 
TABLE - 10 
No Parameters Percentage % 
1 Sensitivity  53% 
2 Specificity  67% 
3 Positive predictive value 83% 
4 Negative predictive value 32% 
5 Pearson chi-square (p) >0.05(NS) 
 
Both sensitivity and specificity is not significantly high for MRC when comparing standard tool 
colonoscopy. 
Negative predictive value is also very low and only the positive predictive value is significant to 
some extent (Table - 10) 
1 - Specificity
1.00.80.60.40.20.0
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0.0
ROC Curve
Diagonal segments are produced by ties.
 
                             ROC – 0.6 
ROC is 0.6 in my study, if ROC is more than 0.8-0.9 then the sensitivity and specificity is better 
and we can recommend that modality. 
In future 3 Tesla MRC may play a role in screening for polyposis and colorectal cancer in 
selected populations but cannot replace the gold standard COLONOSCOPY. 
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 DISCUSSION 
Colonoscopy is the gold standard for evaluation of colonic lesions and also to take biopsy and for 
various therapeutic purposes, however we see lot of obstructing type of rectosigmoid growth 
were passage of scope beyond the lesion was not possible, hence we planned to do  alternative 
investigation,  that is MR Colonography, since MRC is the latest modality it’s not been much 
discussed even in standard gastroenterology and radiology textbooks, but  lot of studies available 
for MRC especially about  its role in polyposis colon, IBD and CRC screening programme. 
MR Colonography is similar to CT Colonography, but it differ from CT colonography in 
following aspects like  
(1). No radiation (2). Need not give nephrotoxic contrast agents (3). Better than CT in staging 
Growth rectum 
After discussing with radiology department professor and asst. Professor i started doing MRC 
with following protocol 
Inclusion and Exclusion criteria as discussed already 
Patient with clinical history and examination strongly suggestive of organic lesion in colon alone 
were included in this study. Patients with history suggestive of functional bowel disorder were 
excluded from the study. 
Out of sixty patients, colonoscopy done first for thirty patients and for the other thirty patients 
MRC done first followed by other modality. 
The diagnostic accuracy of both colonoscopy and MRC is same in 34 patients, however biopsy 
and polypectomy was possible only with colonoscopy. 
The diagnostic accuracy of colonoscopy scores over MRC in twenty one patients  in determining 
various lesions like IBD – Proctitis, Proctosigmoiditis, Left sided colitis and pancolitis, Solitary 
rectal ulcer, Ileocecal TB, Crohn’s disease and Sigmoid diverticulosis with fistula. In all the 
conditions mentioned above in addition to diagnosis, biopsy was taken from suspected lesion for 
HPE confirmation. 
The diagnostic accuracy of MRC scores over colonoscopy in five patients. In one patient growth 
mid descending colon scope passage was not possible beyond the lesion due to obstructing 
growth, but MRC showed a polypoid lesion in splenic flexure in addition to growth mid 
descending colon.  
Among six patients with obstructing growth rectum, were scope passage was not possible 
beyond the lesion, MRC showed a polypoid lesion in descending colon in one patient, thickened 
wall of ascending colon (?Synchronous lesion) in one patient and thickened wall of descending 
colon in another patient (?Synchronous lesion) 
The staging accuracy of Growth Rectum with  MRC and MRI abdomen is better than CT 
Abdomen, we did staging with 1.5 Tesla MRI available in our institution, the staging  accuracy is 
comparable or even superior to CT Abdomen and pelvis, especially to find out the nodal and 
Mesorectal fat involvement. (3 Tesla MRI is superior and very accurate for staging growth 
rectum) 
The diagnostic accuracy of detecting polyp with MRC is more than 90 % if the polyp size is 
more than 5mm. Colonic wall thickening brought out well with MRC if the lesion size is more 
than 5mm. 
Several studies showed poor sensitivity of MRC in detecting polyp of size less than 5 mm, 
however in condition like Familial Adenomatous polyposis, in which colon is studded with 
polyps, it is easy to diagnose polyps even though the size is less than 5mm. 
In my study, one patient with FAP the diagnostic accuracy of both modalities is same. In other 
patient, FAP with growth rectum also the diagnostic accuracy of both modalities are same. 
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SUMMARY AND CONCLUSION 
 
This study includes total of sixty patients with a mean age of 47 years and the male female ratio 
of 2:1 
Among the clinical symptoms and abnormal finding on examination the most common symptom 
being bleeding per rectum seen in 31%, Growth rectum in 21% and suspected IBD-UC in 10% 
and the remaining 38% constitute all other presentation. 
FOBT Positive in 25% of patients with suspected colorectal malignancy, clinically suspected TB 
abdomen in 11% of patients. 
Colonoscopic assessment of the entire colon up to cecum/ileum was possible in forty two 
patients (70%) and in the remaining eighteen patients (30%) scope not passed up to cecum due to 
obstructing lesion in sixteen patients (27%) and the patients intolerance to procedure in two 
patients (3%) in my study. 
Biopsy was taken from all patients with colorectal growth and inflammatory lesions, while doing 
colonoscopy. Biopsy taken from growth arising in Rectum, Sigmoid, and Transverse colon the 
yield rate was 100% and the Histopathology report (HPE) was Adenocarcinoma. Similarly 
Ascending colon growth biopsy revealed 100% positive for malignancy.  
Biopsy from Suspected Ileocecal TB revealed caseating granulomas in 50% and non-specific 
inflammatory infiltrate in another 50% of patients.  
Biopsy taken in patient with familial adenomatous polyposis showed adenomatous polyp 
(100%).  
Biopsy is very important in planning the management which is possible only with colonoscopy 
Out of eight patients with colorectal polyp, polypectomy done for five patients and the remaining 
three patients did not report for polypectomy.  
The obstructing type of lesions (27%) and poor patient tolerance (3%) accounts for 30% 
incomplete study, where in the alternative modality MRC was helpful to evaluate rest of the 
colon.  
Both colonoscopy and MRC detects lesion with same accuracy in thirty four patients (57%), 
colonoscopy detects lesions missed by MRC in twenty one patients (35%) and MRC detects the 
lesion missed by Colonoscopy in five patients (8%), because of non-passage of scope. (Fig - 5)   
Overall accuracy of Colonoscopy is 92% (both modality same accuracy in thirty four patients + 
colonoscopy scores over MRC in twenty one patients) in assessing colonic lesions. (Fig - 5) 
Overall accuracy of MRC is 65% (both modality same accuracy in thirty four patients + MRC 
detects lesion missed by colonoscopy in five patients) in accessing colonic lesion 
Extracolonic findings were detected by MRC in seven patients in addition to colonic lesions viz. 
Pelvic nodes, Liver metastasis, Gall stones. Left Renal calculi and Left sided 
Hydrouretonephrosis 
Statistically while comparing the MRC with standard tool Colonoscopy the Sensitivity - 53% , 
Specificity – 67%, Positive predictive value – 83% and Negative predictive value – 32% and the 
p-value is also not significant (>0.05), suggesting MRC is only an alternate modality if 
colonoscopy is not possible. 
In future 3 Tesla MRI with advanced software may play an important role in evaluation of 
colonic lesions especially for screening Polyposis and Colorectal cancer but still colonoscopy 
will be needed for tissue diagnosis. 
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ANNEXURE 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
STUDY OF COLONOSCOPY AND MRC 
PROFORMA 
Name:    Age/Sex:  IP No: 
Address:       Phone No: 
 
Presenting complaints: 
Abdominal Pain  :  Yes/ No Duration:               days/ months 
     Onset : Rapid/ Insidious   
 Progressive/ Non-progressive 
Loose stool     : Yes/ No Duration:               days/ months 
Mucous    : Yes/ No Duration:               days/ months 
Bleeding PR   : Yes/ No Duration:               days/ months 
Constipation            : Yes/ No Duration:               days/ months 
No.    
Alternate constipation and loose stool                               
  :  Yes/ No Duration:               days/ months 
Wt. loses   : Yes/ No Duration:               days/ months 
Loss of appetite  : Yes/ No Duration:               days/ months 
      
      
Other symptoms  : 
 
 
 
Past History    
H/O Similar episodes in the past 
Co morbid conditions like DM/SHT/IHD 
Previous H/O TB 
 
Personal History: 
Alcohol intake   
Smoking    
Examination   : 
Pallor   
Lymphadenopathy 
Generalised wasting 
Eye manifestation 
Skin and Joint manifestation 
Abdomen  
Mass          Yes/No 
Bowel sounds 
Free fluids 
 
Rectal examination 
 
 
Proctoscopy  
Investigations: 
TC                         DC: N/L/E: 
Platelet count:   ESR: 
FOBT 
    Blood urea 
    Sr. Creatinine 
    HIV I and II 
    USG Abdomen 
 
 
 
 
    Colonoscopy  
 
 
 
  
 
 
 
 
 
    MR  Colonography 
 
 
 
 
     Histopathology  
 
 
 
 
 
        
        
        
        
        
        
        
CONSENT FORM 
 
Title of project:   “COLONOSCOPY AND MR COLONOGRAPHY – A COMPARATIVE 
STUDY” 
Name of the researcher:  Dr. R. Karthikeyan MD 
I confirm that I have read and understand the information provided to me for the above study 
I have had the opportunity to consider the information, ask questions and have had these answered 
satisfactorily.s 
I understand that my participation is voluntary and that I am free to withdraw at anytime, without 
giving any reason, without my medical care or legal rights being affected 
I agree to take part in the above research study. 
 
_______________________                  ______________________          __________________________ 
Name of the patient                                               Date                                                    Signature 
 
_______________________           ______________________          
___________________________ 
Name of the person taking consent                   Date                                                     Signature 
(if different from researcher)  
 
_______________________                 ______________________          
___________________________ 
Researcher                Date                                                     Signature    
 
 
 
 
  
 
 
 
 
 
CHARTS AND PICTURE 
 
 
 
 
 
 
 
 
 
SEX INCIDENCE (Fig ‐ 1) 
SEX
MALE
FEMALE
 
 
AGE INCIDENCE (Fig ‐ 2) 
 
 
 
CLINICAL DIAGNOSIS AT PRESENTATION (Fig ‐ 3) 
 
DURING COLONOSCOPY SCOPE PASSED UP TO (Fig ‐ 4) 
 
 
 
Fig ‐ 5 
DIAGNOSTIC ACCURACY OF BOTH MODALITIES (COLONOSCOPY AND MRC) 
 
 
 
 
OVERALL ACCURACY  
COLONOSCOPY‐92% 
MRC‐65% 
NORMAL APPEARING DARK LUMAN AND BRIGHT LUMEN MRC 
 
                  
 
 
DARK LUMEN MRC WITH LIVER METASTASIS (Fig‐6) 
 
 
 
LIVER METS 
 FAP (Fig‐7) 
                             
 
 
   
                                     
 
                                                       
 
 OBSTRUCTING RECTAL GROWTH (Fig‐8) 
 
                                        
 
ILEOCECAL TB (Fig‐9) 
 
                      
 
 
 
 HISTOPATHOLOGY (Fig‐10) 
 
 
 
Adenocarcinoma
  
Tubular Adenoma
 
                                     
Crohns granuloma
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
